Metropolitan Life Insurance Company (MetLife)’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,035
Closed -$104K 1975
2024
Q1
$104K Sell
3,035
-210
-6% -$7.58K ﹤0.01% 1028
2023
Q4
$120K Sell
3,245
-255
-7% -$5.9K 0.01% 989
2023
Q3
$70.9K Buy
3,500
+310
+10% +$6.81K ﹤0.01% 1202
2023
Q2
$65.3K Hold
3,190
﹤0.01% 1270
2023
Q1
$48.1K Sell
3,190
-289
-8% -$6.38K ﹤0.01% 1411
2022
Q4
$82.8K Hold
3,479
﹤0.01% 1160
2022
Q3
$123K Hold
3,479
0.01% 901
2022
Q2
$122K Hold
3,479
0.01% 946
2022
Q1
$172K Sell
3,479
-9,009
-72% -$499K 0.01% 896
2021
Q4
$966K Hold
12,488
0.01% 990
2021
Q3
$1.34M Sell
12,488
-696
-5% -$79.7K 0.02% 766
2021
Q2
$1.76M Buy
13,184
+673
+5% +$78.2K 0.02% 595
2021
Q1
$1.55M Buy
12,511
+3,227
+35% +$490K 0.02% 666
2020
Q4
$1.31M Hold
9,284
0.02% 703
2020
Q3
$705K Hold
9,284
0.01% 960
2020
Q2
$421K Buy
9,284
+1,696
+22% +$60.9K 0.01% 1344
2020
Q1
$232K Buy
7,588
+178
+2% +$4.79K ﹤0.01% 1510
2019
Q4
$156K Hold
7,410
﹤0.01% 2078
2019
Q3
$177K Buy
7,410
+5,794
+359% +$168K ﹤0.01% 1955
2019
Q2
$46.9K Buy
+1,616
New +$42.7K ﹤0.01% 2512

Other funds holding TWST

Metropolitan Life Insurance Company (MetLife)'s TWST Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Twist Bioscience (TWST) in Q2 2024, closing a stake of 3,035 shares — an estimated $104K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TWST in Q2 2019 and held it in 20 quarters. The position peaked at $1.76M in Q2 2021. 263 funds tracked by Wall St. Rank hold TWST as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Twist Bioscience position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,035 Twist Bioscience shares in Q2 2024, an estimated $104K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Twist Bioscience in Q2 2019 and held it in 20 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Twist Bioscience position peaked at $1.76M in Q2 2021.
  • 263 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.